SCHEMBL14842380

SCHEMBL14842380

O=C(O)c1ccc(CN(C2CCCCC2)S(=O)(=O)c2ccc(F)cc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 1.00
▸ KMT2A Q03164 1/20 1.00
▸ HDAC8 Q9BY41 2/20 0.68
▸ HDAC6 Q9UBN7 2/20 0.68
▸ HDAC3 O15379 1/20 0.68
▸ NPSR1 Q6W5P4 1/20 0.66
▸ ALDH1A1 P00352 2/20 0.65
▸ USP2 O75604 1/20 0.65
▸ TAS2R14 Q9NYV8 5/20 0.59
▸ MAPT P10636 1/20 0.54
▸ THRB P10828 1/20 0.54
▸ CNR1 P21554 2/20 0.53
▸ CNR2 P34972 2/20 0.53
▸ PTGES O14684 1/20 0.53
▸ AGER Q15109 2/20 0.52
▸ MTNR1A P48039 1/20 0.52
▸ PSEN1 P49768 1/20 0.52
▸ PSEN2 P49810 1/20 0.52
▸ APH1B Q8WW43 1/20 0.52
▸ NCSTN Q92542 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14842203 0.88 MEN1 (0.79) MEN1KMT2AHDAC8HDAC6HDAC3
SCHEMBL14842844 0.86 MEN1 (0.76) MEN1KMT2AHDAC8HDAC6HDAC3
SCHEMBL20847632 0.83 HDAC8 (0.74) MEN1KMT2AHDAC8HDAC6HDAC3
SCHEMBL20393935 0.82 MEN1 (0.69) MEN1KMT2AHDAC8HDAC6HDAC3
SCHEMBL20393932 0.81 KMT2A (0.69) MEN1KMT2AHDAC8HDAC6HDAC3
SCHEMBL15969664 0.81 MEN1 (0.67) MEN1KMT2ANPSR1USP2TAS2R14
SCHEMBL20387947 0.80 KMT2A (0.67) MEN1KMT2AHDAC8HDAC6HDAC3
SCHEMBL26159101 0.80 PTGES (0.68) MEN1KMT2ANPSR1TAS2R14CNR1
SCHEMBL20839243 0.79 HDAC8 (0.65) MEN1KMT2AHDAC8HDAC6HDAC3
SCHEMBL14842982 0.79 MEN1 (0.65) MEN1KMT2AHDAC8HDAC6HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140243374-A1 Novel Sulfonamides BRIGHAM & WOMENS HOSPITAL (US) 2014-08-28 — — US disclosed
US-20140243374-A1 Novel Sulfonamides BRIGHAM & WOMENS HOSPITAL (US) 2014-08-28 — — US disclosed
US-20140243374-A1 Novel Sulfonamides BRIGHAM & WOMENS HOSPITAL (US) 2014-08-28 — — US disclosed
WO-2013052700-A1 NOVEL SULFONAMIDES THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2013-04-11 — — WO disclosed
WO-2013052700-A1 NOVEL SULFONAMIDES THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2013-04-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140243374-A1 Novel Sulfonamides BACE1, BACE2, GSAP MEN1 2751/4885KMT2A 1573/4885HDAC8 285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback